BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 15364002)

  • 1. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors.
    Toth G; Kramer TH; Knapp R; Lui G; Davis P; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1990 Jan; 33(1):249-53. PubMed ID: 2153205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine.
    Fox-Threlkeld JE; Daniel EE; Christinck F; Hruby VJ; Cipris S; Woskowska Z
    J Pharmacol Exp Ther; 1994 Feb; 268(2):689-700. PubMed ID: 8113980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
    J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
    Shook JE; Pelton JT; Wire WS; Hirning LD; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Mar; 240(3):772-7. PubMed ID: 2882015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM; Traynor JR
    Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
    Rónai AZ; Magyar A; Orosz G; Borsodi A; Benyhe S; Tóth G; Makó E; Kátay E; Babka E; Medzihradszky K
    Arch Int Pharmacodyn Ther; 1995; 330(3):361-9. PubMed ID: 8836454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
    Riba P; Tóth Z; Hosztafi S; Friedmann T; Fürst S
    Acta Biol Hung; 2003; 54(2):177-81. PubMed ID: 14535623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y; Simon EJ
    J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.